Several other studies examined the effects of SGLT2 inhibitors on NAFLD but, to the best of the authors’ knowledge, no histological data on the effect of gliflozin on NAFLD are available yet [250]. The gene discussed is SLC5A2; the disease is metabolic dysfunction-associated steatotic liver disease.